Hong Kong: Hong Kong Moves to Amend Legislation to Include CBD as a Dangerous Drug

  |   Attaché Report (GAIN)   |   HK2022-0015

In the past, the eligibility of food and non-food products containing cannabidiol (CBD) in the Hong Kong market has been ambiguous. The Hong Kong government now is prepared to remove this ambiguity by moving forward with a legislative amendment to control CBD under the Dangerous Drugs Ordinance. In addition, as Hong Kong maintains a zero-tolerance policy for tetrahydrocannabinol (THC), the government has pledged that, it will continue to test CBD products in the market and seize products found to contain THC.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.